Skip to main content

N-Acetyl aspartate/(Creatine and Phosphocreatine) ratio


Basic information
Metabolite name

N-Acetyl aspartate/(Creatine and Phosphocreatine) ratio

N/A
N/A
N/A
Synonyms

N-acetylasparte/(Creatine and Phosphocreatine) ratio;
N-acetyl aspartate/(Creatine and Phosphocreatine) ratios;
N-acetylaspartate/(Creatine and Phosphocreatine) ratio;
N-acetyl-asparte/(Creatine and Phosphocreatine) ratio;
N-acetyl-L-aspartate/(Creatine and Phosphocreatine) ratio;
N-Acetyl-L-aspartic acid/(Creatine and Phosphocreatine) ratio;
N-acetyl-aspartate/(Creatine and Phosphocreatine) ratio;
N-acetylaspartate/Creatine and Phosphocreatine ratio

No. of studies

54

 

Relationship between N-Acetyl aspartate/(Creatine and Phosphocreatine) ratio and depression (count: 54)
Study Study Type Comparison groups Tissue Organism Up/Down regulated
Study M1050 Type1 MDD without gastrointestinal symptoms group vs. control group Anterior cingulate gyrus Human Down
Study M1050 Type1 MDD with gastrointestinal symptoms group vs. control group Anterior cingulate gyrus Human Down
Study M1050 Type1 MDD without gastrointestinal symptoms group vs. control group Thalamus Human Down
Study M1050 Type1 MDD with gastrointestinal symptoms group vs. control group Thalamus Human Down
Study M211 Type2 depression group post-treatment vs. baseline Brain Human Up
Study M227 Type1 depression group vs. control group Dorsolateral prefrontal cortex Human Down
Study M228 Type1 depression group vs. control group Frontal lobe Human Down
Study M238 Type1 depression group vs. control group Caudate Human Down
Study M249 Type1 TBI with depression group vs. control group Basal ganglia Human Down
Study M251 Type2 depression group post-treatment vs. pre-treatment Medial frontal cortex Human Up
Study M257 Type1 depression group vs. control group Thalamus Human Down
Study M259 Type1 depression group vs. control group Hippocampus Human Down
Study M259 Type1 depression group vs. control group Frontal lobe Human Down
Study M259 Type2 SSRI-treated depression group post-treatment vs. pre-treatment Frontal lobe Human Up
Study M259 Type2 SSRI-treated depression group post-treatment vs. pre-treatment Hippocampus Human Up
Study M261 Type1 depression group vs. control group Hippocampus Human Down
Study M265 Type1 unmedicated depression group vs. control group Frontal white matter Human Down
Study M268 Type1 depression group vs. control group Hippocampus Human Down
Study M273 Type2 fluoxetine group post-treatment vs. pre-treatment Hippocampus Human Up
Study M273 Type2 fluoxetine group post-treatment vs. pre-treatment Frontal lobe Human Up
Study M273 Type2 EA + fluoxetine group post-treatment vs. pre-treatment Frontal lobe Human Up
Study M273 Type2 EA + fluoxetine group post-treatment vs. pre-treatment Hippocampus Human Up
Study M275 Type1 depression group vs. control group Thalamus Human Down
Study M275 Type1 depression group vs. control group Hippocampus Human Down
Study M275 Type2 paroxetine-treated depression group post-treatment vs. pre-treatment Hippocampus Human Up
Study M275 Type2 paroxetine-treated depression group post-treatment vs. pre-treatment Thalamus Human Up
Study M284 Type2 MS + EE group vs. MS group Hippocampus Sprague-Dawley rat Up
Study M288 Type1 CUMS group vs. control group Hippocampus Sprague-Dawley rat Down
Study M288 Type2 CUMS + escitalopram group vs. CUMS group Hippocampus Sprague-Dawley rat Up
Study M298 Type2 escitalopram group vs. placebo group Medial frontal cortex Human Up
Study M300 Type2 depression group post-treatment vs. pre-treatment Hippocampus Human Up
Study M301 Type1 depression group vs. control group Dorsolateral prefrontal white matter Human Down
Study M306 Type1 depression group vs. control group Hippocampus Human Down
Study M308 Type1 moderate depression group vs. control group Prefrontal cortex Human Down
Study M311 Type1 OSAHS group vs. control group Frontal white matter Human Down
Study M315 Type1 AD with depression group vs. AD without depression group Anterior cingulate gyrus Human Down
Study M319 Type1 depression group vs. control group Prefrontal cortex Human Down
Study M319 Type1 depression group vs. control group Hippocampus Human Down
Study M320 Type1 depression group vs. control group Anterior cingulate cortex Human Down
Study M320 Type2 rTMS responder group post-treatment vs. pre-treatment Anterior cingulate cortex Human Up
Study M320 Type4 rTMS responder group vs. rTMS non-responder group Anterior cingulate cortex Human Up
Study M321 Type1 depression group vs. control group Prefrontal lobe white matter Human Down
Study M326 Type1 depression group vs. control group Anterior cingulate cortex Human Down
Study M326 Type2 MBCT-treated depression group post-treatment vs. pre-treatment Anterior cingulate cortex Human Up
Study M332 Type1 depression group vs. control group Dorsolateral prefrontal white matter Human Down
Study M334 Type1 depression group vs. control group Dorsal prefrontal cortex Human Down
Study M343 Type1 severe depression group vs. control group Thalamus Human Down
Study M343 Type1 moderate depression group vs. control group Thalamus Human Down
Study M343 Type1 depression group vs. control group Thalamus Human Down
Study M351 Type1 depression group vs. control group Thalamus Human Down
Study M363 Type2 ECT-treated depression group post-treatment vs. pre-treatment Hippocampus Human Down
Study M365 Type1 depression group vs. control group Prefrontal cortex Human Down
Study M366 Type1 CMS group vs. control group Ventral hippocampus Long-Evans rat Up
Study M367 Type1 METH group vs. control group Frontal cortex C57BL/6 mouse Down
Study M468 Type1 depression group vs. control group Prefrontal cortex Human Up
Study M468 Type1 depression group vs. control group Hippocampus Human Up
Study M468 Type2 depression group post-exercise vs. pre-exercise Hippocampus Human Down
Study M538 Type2 MDD group, after rTMS treatment vs. baseline Dorsolateral prefrontal cortex Human Up
Study M580 Type1 CUMS group vs. control group Hippocampus Sprague-Dawley rat Down
Study M580 Type1 CUMS group vs. control group Prefrontal cortex Sprague-Dawley rat Down
Study M612 Type1 MDD group vs. control group Anterior cingulate cortex Human Down
Study M624 Type1 cognitive impairment with depression group vs. cognitive impairment group Frontal white matter Human Down
Study M624 Type1 cognitive impairment with depression group vs. cognitive impairment group Hippocampus Human Up
Study M637 Type1 MDD group vs. control group Prefrontal cortex Human Down
Study M660 Type1 ESRD with depression vs. ESRD without depression Frontal lobe Human Down
Study M694 Type1 depression group vs. control group Posterior cingulate Human Down
Study M752 Type1 PSD group vs. control group Hippocampus Wistar rat Down
Study M752 Type1 CUMS group vs. control group Hippocampus Wistar rat Down
Study M752 Type1 PSD group vs. control group Prefrontal cortex Wistar rat Down
Study M752 Type1 CUMS group vs. control group Prefrontal cortex Wistar rat Down
Study M752 Type2 PSD + Yi-nao-jie-yu decoction group vs. PSD group Hippocampus Wistar rat Up
Study M752 Type2 PSD + Yi-nao-jie-yu decoction group vs. PSD group Prefrontal cortex Wistar rat Up
Study M765 Type1 MDD group vs. control group Lenticular nucleus Human Down
Study M812 Type1 MDD group vs. control group Hippocampus Human Down
Study M855 Type1 MDD group vs. control group Thalamus Human Up
Study M855 Type1 MDD group vs. control group Prefrontal cortex Human Down
Study M864 Type2 psilocybin group, posttreatment vs. baseline Anterior cingulate cortex Human Down
Study M895 Type1 MDD with childhood trauma group vs. control group Anterior cingulate cortex Human Down
Study M895 Type1 MDD with childhood trauma group vs. control group Putamen Human Down
Study M895 Type1 MDD without childhood trauma group vs. control group Cerebellum Human Up
Study M895 Type1 MDD without childhood trauma group vs. control group Anterior cingulate cortex Human Down
Study M895 Type1 MDD with childhood trauma group vs. control group Cerebellum Human Up
Study M895 Type1 MDD without childhood trauma group vs. control group Putamen Human Down
Study M899 Type1 depression with non-suicidal self-injury group vs. control group Thalamus Human Up
Study M899 Type1 depression without non-suicidal self-injury group vs. control group Prefrontal cortex Human Down
Study M899 Type1 depression with non-suicidal self-injury group vs. control group Lenticular nucleus Human Down
Study M914 Type1 depression with anxiety group vs. control group Dorsal anterior cingulate cortex Human Down
Study M914 Type1 depression with anxiety group vs. control group Pregenual anterior cingulate cortex Human Down
Study M925 Type1 MDD group vs. control group Prefrontal cortex Human Down
Study M954 Type2 modified electroconvulsive therapy group vs. control treatment group Prefrontal white matter and anterior cingulate cortex Human Up
Study M973 Type1 MDD group vs. control group Cerebellum Human Down